期刊文献+

欧盟药品注册、企业生产许可证及GMP检查的相互关系 被引量:1

Relationship Among Drug Marketing Authorization,Manufacturing Authorization as Well as GMP Inspection
下载PDF
导出
摘要 目的探讨当前形势下我国药事管理改革的措施。方法研究ICH近年颁布的Q系列文件,并结合欧盟药品注册、GMP检查、制药企业生产许可证管理等药事管理法规与规定,讨论欧盟药品注册、企业生产许可证及GMP检查的若干相互关系。结果与结论欧盟药品监管体系成熟,其某些举措可供我国药事管理制度改革时参考。 Objective To discuss reformation measures of Chinese administration of pharmaceutical affair in current situation.Methods The Q series guidelines published by ICH recently were studied.The rules and regulations governing medicinal products in European Union,some topics of the relationship among approval of drug marketing authorization,management of manufacturing authorization as well as GMP inspection within European Union were discussed.Results and Conclusions The system of European drug administration is well developed and efficient. Some aspects of the system may use as referenee and are valuable for the reformation of Chinese administration of pharmaceutical affair.
作者 马涛
出处 《中国药事》 CAS 2009年第10期1027-1029,1036,共4页 Chinese Pharmaceutical Affairs
关键词 药事管理 药品注册 GMP检查 药品生产许可证 欧盟 administration of pharmaceutical affair drug registration GMP inspection manufacturing authorization European Union
  • 相关文献

参考文献9

  • 1ICH Harmonized Tripartite Guideline, Pharmaceutical Development QS, Current Step 4 version[S] . 10 Nov, 2005.
  • 2ICH Harmonized Tripartite Guideline, Quality Risk Management Q9, Current Step 4 version [S]. 9 Nov, 2005.
  • 3ICH Harmonized Tripartite Guideline, Pharmaceutical Quality System Q10, Current Step 4 version [S] . 4 June, 2008.
  • 4欧盟药监局官方网站[EB/OL].E2008-06一05].http://www.emea.europa.eu/.
  • 5The European Parliament and the Council of the European Union, Directive 2001/83/EC On the Community Code Relating to Medidnal Products For Human Use, 6, Artide 40 [S] .Nov, 2001.
  • 6Conduct of Inspections of Pharmaceutical Manufacturers [S]. 20 Sep, 2006.
  • 7Coordination of Pre-approval GxP Inspection[S]. 27 April, 2007.
  • 8药品管理法[S].中华人民共和国主席令第45号,2001.
  • 9药品生产质量管理规范[S].国家药品监督管理局令第9号,1998.

共引文献19

同被引文献12

  • 1黄洲萍,王一涛.欧盟、中国制剂药生产质量管理规范比较[J].中国卫生事业管理,2007,23(8):539-540. 被引量:3
  • 2Food and Drug Administration, HHS. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labe- ling controls. Final rule[J]. Fed Regist, 2012, 77 (54) . 16158-16163.
  • 3Jackman M, Woods K. An overview of the European Union's new medicines legislation [J]. Int J Pharm Med, 2006, 20(4) :251-261.
  • 4Cerreta F,Eichler HG, Rasi G. Drug policy for anaging population-the European Medicines Agency's geriatric medicines strategy[J. N Engl J Med, 2012,367(21): 1972-1974.
  • 5Sahoo N, Choudhury K, Manchikanti P. Manufacturing of biodrugs., need for harmonization in regulatory standards[-J]. BioDrugs, 2009, 23(4); 217-229.
  • 6Maggioni AP, Dame B, Atar D, et al. FDA and CPMP rulings on subgroup analyses[J-I, Cardiology, 2007107(2) . 97-102.
  • 7Mor6nas J. PICAS: pharmaceutical inspection coopera- tion schemeD-]. Ann Pharm Fr, 2009, 67(1) : 16-19.
  • 8PIC/S introduction[-EB/OL, http://www, picscheme. org/pics, php.
  • 9Darpo B, Nebout T, Sager PT. Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic dugs. the International Conference on Harmonization of Technical Requirements for Reg- istration of Pharmaceuticals for Human Use El4 guide- line[-J. J Clin Pharmacol, 2006, 46(5) .498-507.
  • 10Pharmaceutical Quality System Q10[EB/OL]. http:// www. ich. org/products/guidelines/quality/quality-sin- gle/article/pharmaceutical-quality-systcm, html, 2008 - 6-4.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部